Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0005 | 0.0093 | 0.0423 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0027 | 0.1048 | 1 |
Trypanosoma cruzi | ferric reductase transmembrane protein, putative | 0.0139 | 0.6128 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0052 | 0.2194 | 0.3481 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.1954 | 0.8858 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.1954 | 0.8907 |
Giardia lamblia | hypothetical protein | 0.0005 | 0.0093 | 0.0423 |
Echinococcus multilocularis | exonuclease 1 | 0.0005 | 0.0093 | 0.0423 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.1954 | 0.8858 |
Brugia malayi | XPG I-region family protein | 0.0005 | 0.0093 | 0.0093 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0027 | 0.1048 | 0.4775 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.1954 | 0.8858 |
Trypanosoma brucei | ferric reductase transmembrane protein, putative | 0.0139 | 0.6128 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.1954 | 0.8907 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0052 | 0.2194 | 1 |
Plasmodium falciparum | flap endonuclease 1 | 0.0027 | 0.1048 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0052 | 0.2194 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0052 | 0.2194 | 1 |
Toxoplasma gondii | XPG N-terminal domain-containing protein | 0.0005 | 0.0093 | 0.0423 |
Trypanosoma cruzi | ferric reductase transmembrane protein, putative | 0.0139 | 0.6128 | 1 |
Echinococcus multilocularis | DNA repair protein complementing XP G cells | 0.0005 | 0.0093 | 0.0423 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0.0093 | 0.0093 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0052 | 0.2194 | 0.2194 |
Onchocerca volvulus | Dual oxidase homolog | 0.0225 | 1 | 1 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0005 | 0.0093 | 0.0423 |
Giardia lamblia | Exonuclease 1 | 0.0005 | 0.0093 | 0.0423 |
Entamoeba histolytica | Flap nuclease, putative | 0.0027 | 0.1048 | 0.6379 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.1954 | 0.1954 |
Echinococcus granulosus | flap endonuclease 1 | 0.0027 | 0.1048 | 0.4775 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0052 | 0.2194 | 0.3481 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.3722 | 0.3722 |
Brugia malayi | MAP kinase sur-1 | 0.0052 | 0.2194 | 0.2194 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0027 | 0.1048 | 0.1582 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0052 | 0.2194 | 0.3481 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0052 | 0.2194 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0052 | 0.2194 | 0.3481 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0027 | 0.1048 | 0.4775 |
Echinococcus granulosus | exonuclease 1 | 0.0005 | 0.0093 | 0.0423 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0027 | 0.1048 | 0.4775 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0005 | 0.0093 | 0.0423 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0052 | 0.2194 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0052 | 0.2194 | 0.3481 |
Trypanosoma brucei | protein kinase, putative | 0.0052 | 0.2194 | 0.3481 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0052 | 0.2194 | 0.3481 |
Toxoplasma gondii | XPG N-terminal domain-containing protein | 0.0005 | 0.0093 | 0.0423 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0027 | 0.1048 | 0.1048 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.1642 | 1 |
Schistosoma mansoni | flap endonuclease-1 | 0.0024 | 0.0932 | 0.3996 |
Entamoeba histolytica | DNA-repair protein, putative | 0.0005 | 0.0093 | 0.0566 |
Treponema pallidum | hypothetical protein | 0.004 | 0.1642 | 0.5 |
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.0225 | 1 | 1 |
Plasmodium falciparum | DNA repair protein RAD2, putative | 0.0005 | 0.0093 | 0.0887 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0027 | 0.1048 | 0.1582 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0052 | 0.2194 | 1 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0052 | 0.2194 | 1 |
Entamoeba histolytica | exonuclease, putative | 0.0005 | 0.0093 | 0.0566 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0052 | 0.2194 | 0.3481 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0027 | 0.1048 | 0.4775 |
Toxoplasma gondii | XPG N-terminal domain-containing protein | 0.0005 | 0.0093 | 0.0423 |
Loa Loa (eye worm) | XPG I-region family protein | 0.0005 | 0.0093 | 0.0093 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0027 | 0.1048 | 0.1582 |
Echinococcus granulosus | DNA repair protein complementing XP G cells | 0.0005 | 0.0093 | 0.0423 |
Echinococcus multilocularis | flap endonuclease GEN 1 | 0.0005 | 0.0093 | 0.0423 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0052 | 0.2194 | 1 |
Echinococcus granulosus | flap endonuclease GEN 1 | 0.0005 | 0.0093 | 0.0423 |
Leishmania major | ferric reductase, putative | 0.0139 | 0.6128 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.1954 | 0.1954 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0.0093 | 0.0093 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0052 | 0.2194 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0052 | 0.2194 | 1 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0052 | 0.2194 | 1 |
Trichomonas vaginalis | exonuclease%2C+putative | 0.0005 | 0.0093 | 0.0423 |
Entamoeba histolytica | exonuclease, putative | 0.0005 | 0.0093 | 0.0566 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.1954 | 0.8907 |
Toxoplasma gondii | XPG N-terminal domain-containing protein | 0.0005 | 0.0093 | 0.0423 |
Plasmodium falciparum | exonuclease I, putative | 0.0005 | 0.0093 | 0.0887 |
Brugia malayi | Flap endonuclease-1 | 0.0027 | 0.1048 | 0.1048 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0005 | 0.0093 | 0.0423 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.1954 | 0.8907 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 32.6294 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.